应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09996 沛嘉医疗-B
交易中 11-19 11:29:14
3.870
-0.100
-2.52%
最高
3.870
最低
3.870
成交量
3,000
今开
3.870
昨收
3.970
日振幅
0.00%
总市值
25.87亿
流通市值
25.89亿
总股本
6.69亿
成交额
1.16万
换手率
0.00%
流通股本
6.69亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
规范经营行为 筑牢安全防线
南宁日报 · 05:42
规范经营行为 筑牢安全防线
乐心医疗最新公告:瑞康宏业申请的医疗器械生产许可证延续事项已通过审批
证券之星 · 11-18 20:20
乐心医疗最新公告:瑞康宏业申请的医疗器械生产许可证延续事项已通过审批
助听器线上销售乱象调查;回顾第15届中国航展精彩瞬间
新京报 · 11-18 19:31
助听器线上销售乱象调查;回顾第15届中国航展精彩瞬间
5部门联合印发——顺义区将建设高端医疗器械集聚区
北京时间 · 11-18 19:03
5部门联合印发——顺义区将建设高端医疗器械集聚区
正海生物(300653.SZ):钙硅生物陶瓷骨修复材料医疗器械注册申请获受理
智通财经 · 11-18 16:34
正海生物(300653.SZ):钙硅生物陶瓷骨修复材料医疗器械注册申请获受理
伟思医疗(688580.SH)取得2项医疗器械注册证
智通财经 · 11-18 15:36
伟思医疗(688580.SH)取得2项医疗器械注册证
国家药监局局长李利率团访问越南和泰国 签署合作谅解备忘录
美港电讯 · 11-18 12:52
国家药监局局长李利率团访问越南和泰国 签署合作谅解备忘录
沛嘉医疗(09996.HK)TaurusTrio经导管主动脉瓣置换系统完成香港首例同情救治使用
阿斯达克财经 · 11-18 08:50
沛嘉医疗(09996.HK)TaurusTrio经导管主动脉瓣置换系统完成香港首例同情救治使用
柔性执法为经营主体减负松绑
媒体滚动 · 11-18 08:00
柔性执法为经营主体减负松绑
沛嘉医疗-B(09996)成功完成TaurusTrioTM TAVR系统中国香港首例同情救治使用
智通财经 · 11-18 07:50
沛嘉医疗-B(09996)成功完成TaurusTrioTM TAVR系统中国香港首例同情救治使用
积极捡拾筹码 百亿级私募11月初仓位创今年以来新高
美港电讯 · 11-18 04:54
积极捡拾筹码 百亿级私募11月初仓位创今年以来新高
百亿级股票私募仓位指数创今年以来单周加仓幅度最高纪录
美港电讯 · 11-16 21:39
百亿级股票私募仓位指数创今年以来单周加仓幅度最高纪录
我国在研新药数量跃居全球第二 后续将推动医药工业转型升级
美港电讯 · 11-16 15:04
我国在研新药数量跃居全球第二 后续将推动医药工业转型升级
陕西平利县一乡村卫生室使用过期导尿包,市监局:罚款2万元
澎湃新闻 · 11-16 12:20
陕西平利县一乡村卫生室使用过期导尿包,市监局:罚款2万元
【ETF动向】11月15日平安医药及医疗器械创新ETF基金跌2.2%,份额增加2.78亿份
证券之星 · 11-16
【ETF动向】11月15日平安医药及医疗器械创新ETF基金跌2.2%,份额增加2.78亿份
山外山新注册《基于UDI的医疗器械耗材防伪标识系统V2.0》项目的软件著作权
证券之星 · 11-16
山外山新注册《基于UDI的医疗器械耗材防伪标识系统V2.0》项目的软件著作权
刘泽凡:医疗器械出海如何提升竞争力?
中新经纬 · 11-15
刘泽凡:医疗器械出海如何提升竞争力?
沛嘉医疗-B盘中异动 下午盘快速上涨5.45%报4.060港元
市场透视 · 11-15
沛嘉医疗-B盘中异动 下午盘快速上涨5.45%报4.060港元
苏州工业园区:加速发展高端产业
美港电讯 · 11-15
苏州工业园区:加速发展高端产业
港股异动 | 高视医疗(02407)涨超3% 人工晶状体植入系统获得医疗器械注册证
智通财经 · 11-15
港股异动 | 高视医疗(02407)涨超3% 人工晶状体植入系统获得医疗器械注册证
加载更多
公司概况
公司名称:
沛嘉医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
Peijia Medical Ltd是一家主要从事介入手术医疗器械研发业务的中国控股公司。通过其子公司,该公司主要运营两个业务部门。经导管瓣膜治疗业务部门主要从事研发经导管瓣膜治疗医疗器械业务。神经介入业务部门从事研发神经介入手术医疗器械业务。该公司的主要在研产品包括TaurusOne、TaurusElite和TaurusNXT等。该公司主要在中国境内开展业务。
发行价格:
--
{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":3.87,"timestamp":1731986530838,"preClose":3.97,"halted":0,"volume":3000,"delay":0,"floatShares":669000000,"shares":668517808,"eps":-0.62181085,"marketStatus":"交易中","marketStatusCode":2,"change":-0.1,"latestTime":"11-19 11:29:14","open":3.87,"high":3.87,"low":3.87,"amount":11610,"amplitude":0,"askPrice":3.96,"askSize":7000,"bidPrice":3.87,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":-0.3982095318324371,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1731988800000},"adr":0,"listingDate":1589472000000,"adjPreClose":3.97,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0.016487,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996","defaultTab":"news","newsList":[{"id":"2484844519","title":"规范经营行为 筑牢安全防线","url":"https://stock-news.laohu8.com/highlight/detail?id=2484844519","media":"南宁日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484844519?lang=zh_cn&edition=full","pubTime":"2024-11-19 05:42","pubTimestamp":1731966120,"startTime":"0","endTime":"0","summary":"近日,南宁市市场监管局组织召开医疗器械网络经营企业合规经营指导座谈会,进一步规范医疗器械网络销售行为,引导企业合规经营。 接下来,南宁市市场监管局将持续加大对医疗器械网络经营企业的跟踪检查和监测力度,督促企业严格履行主体责任,规范经营行为,确保网络销售医疗器械质量安全。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-19/doc-incwptzv2961567.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-19/doc-incwptzv2961567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09997","BK1222","09996","BK1100","BK1583","BK1574"],"gpt_icon":0},{"id":"2484290796","title":"乐心医疗最新公告:瑞康宏业申请的医疗器械生产许可证延续事项已通过审批","url":"https://stock-news.laohu8.com/highlight/detail?id=2484290796","media":"证券之星","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484290796?lang=zh_cn&edition=full","pubTime":"2024-11-18 20:20","pubTimestamp":1731932435,"startTime":"0","endTime":"0","summary":"乐心医疗控股子公司瑞康宏业近日收到广东省药品监督管理局下发的《医疗器械生产许可证》,其医疗器械生产许可证延续事项已通过审批。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800028941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK0114","BK1222","09996","300562","159883","09997","BK0251","BK0109","BK1574","BK1100"],"gpt_icon":0},{"id":"2484101625","title":"助听器线上销售乱象调查;回顾第15届中国航展精彩瞬间","url":"https://stock-news.laohu8.com/highlight/detail?id=2484101625","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484101625?lang=zh_cn&edition=full","pubTime":"2024-11-18 19:31","pubTimestamp":1731929460,"startTime":"0","endTime":"0","summary":"此次事故未造成人员伤亡,此为不幸中的万幸。这一初步判断,应该为后续的调查提供了重要线索。记者陶冉也守在本届航展现场记录军机的精彩飞行瞬间。歼-20本届航展中,4架歼-20组成“钻石”编队,完成了精彩的飞行表演。八一飞行表演队这是空军八一飞行表演队的第十一次中国航展之旅,同时也是表演队换装歼-10C战机后首次亮相中国航展。这是俄罗斯“勇士”飞行表演队阔别8年后,亮相第十五届中国航展。","market":"us","thumbnail":"https://media.bjnews.com.cn/cover/2024/11/18/5522649777671578447.png?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2024/11/18/5522649777671578447.png?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1731926700129592.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1731926700129592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["09996","BK1100","BK1574","BK1222","BK1583","09997"],"gpt_icon":0},{"id":"2484628664","title":"5部门联合印发——顺义区将建设高端医疗器械集聚区","url":"https://stock-news.laohu8.com/highlight/detail?id=2484628664","media":"北京时间","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484628664?lang=zh_cn&edition=full","pubTime":"2024-11-18 19:03","pubTimestamp":1731927780,"startTime":"0","endTime":"0","summary":"文件指出,顺义区高端医疗器械集聚区将依托区内空间载体和存量优质企业,围绕血管及神经介入、骨科植入、口腔生物材料等高值医用耗材,体外诊断设备及试剂,高端医学影像设备及人工智能辅助诊断软件,口腔数字诊疗装备、手术系统及手术机器人等重点领域,引入检验检测、医疗器械注册、临床转化服务等产业配套服务,完善产业生态。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-18/doc-incwnsqi3513741.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-18/doc-incwnsqi3513741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09997","159883","BK1222","BK1100","BK1574","09996","BK1583"],"gpt_icon":0},{"id":"2484648385","title":"正海生物(300653.SZ):钙硅生物陶瓷骨修复材料医疗器械注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2484648385","media":"智通财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484648385?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:34","pubTimestamp":1731918861,"startTime":"0","endTime":"0","summary":"智通财经APP讯,正海生物(300653.SZ)公告,公司近日收到国家药品监督管理局下发的医疗器械注册申请《受理通知书》,相关产品名称为:钙硅生物陶瓷骨修复材料,适用于颌骨缺损(或骨量不足)的填充和修复。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1222","BK1574","300653","09996","BK0251","09997","159883","BK1100","BK0046"],"gpt_icon":0},{"id":"2484112726","title":"伟思医疗(688580.SH)取得2项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2484112726","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484112726?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:36","pubTimestamp":1731915402,"startTime":"0","endTime":"0","summary":"智通财经APP讯,伟思医疗(688580.SH)发布公告,公司于近日收到了由江苏省药品监督管理局颁发的2项《医疗器械注册证》,产品名称:多功能生物刺激反馈仪、生物刺激反馈仪。上述拿证的多功能生物刺激反馈仪产品主要是用于神经和肌肉受损功能的恢复,是市场主流的康复物理治疗产品,广泛运用于医院神经康复相关科室。新款生物刺激反馈仪是公司原有盆底电刺激产品的全面升级迭代,主要是用于各类盆底功能障碍疾病的治疗,广泛运用于医院妇产、盆底中心相关科室。上述《医疗器械注册证》的取得,将有利于进一步扩展和优化公司物理因子治疗产品线,提升公司电刺激类产品在盆底康复与康复理疗市场的综合竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1222","BK0251","159883","BK1583","BK1574","09997","688580","BK1100"],"gpt_icon":0},{"id":"2484767691","title":"国家药监局局长李利率团访问越南和泰国 签署合作谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=2484767691","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484767691?lang=zh_cn&edition=full","pubTime":"2024-11-18 12:52","pubTimestamp":1731905520,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["TNmain","BK1222","ZFmain","BK1583","ZBmain","ZTmain","ZNmain","09996","159883","BK1574","UBmain","09997","BK1100"],"gpt_icon":0},{"id":"2484663426","title":"沛嘉医疗(09996.HK)TaurusTrio经导管主动脉瓣置换系统完成香港首例同情救治使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2484663426","media":"阿斯达克财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484663426?lang=zh_cn&edition=full","pubTime":"2024-11-18 08:50","pubTimestamp":1731891000,"startTime":"0","endTime":"0","summary":"沛嘉医疗(09996.HK) 公布,最近用于治疗有症状的重度主动脉瓣反流(AR)的产品TaurusTrio经导管主动脉瓣置换(TAVR)系统,已成功完成香港首例同情救治使用。公司指出,今年1月已就在中国开展的TaurusTrioTM TAVR系统多中心注册临床试验完成患者入组。后续阶段的随访评估正在进行中。公司预期在中国获得监管批准后将此产品商品化,以迎合广大AR患者尚未满足的需求。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200911173949988_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200911173949988_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1397253&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09996","BK1574","159891","BK1583","BK1100"],"gpt_icon":0},{"id":"2484248668","title":"柔性执法为经营主体减负松绑","url":"https://stock-news.laohu8.com/highlight/detail?id=2484248668","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484248668?lang=zh_cn&edition=full","pubTime":"2024-11-18 08:00","pubTimestamp":1731888000,"startTime":"0","endTime":"0","summary":"今年以来,市市场监管局在全市深入推进包容审慎监管,全面落实“轻微免罚”措施,以行政指导、告诫约谈、跟踪执法等梯次监管方式代替以往强制性行政处罚,切实减轻广大经营主体特别是中小企业负担,持续优化营商环境。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-18/doc-incwmvkv0524617.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-18/doc-incwmvkv0524617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","BK1222","BK1574","09997","BK1100","BK1583"],"gpt_icon":0},{"id":"2484626668","title":"沛嘉医疗-B(09996)成功完成TaurusTrioTM TAVR系统中国香港首例同情救治使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2484626668","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484626668?lang=zh_cn&edition=full","pubTime":"2024-11-18 07:50","pubTimestamp":1731887406,"startTime":"0","endTime":"0","summary":"智通财经APP讯,沛嘉医疗-B(09996)发布公告,公司董事会欣然宣布,最近,集团用于治疗有症状的重度主动脉瓣反流(AR)的产品TaurusTrioTM经导管主动脉瓣置换(TAVR)系统已成功完成中国香港首例同情救治使用。于2024年1月,公司已就在中国开展的TaurusTrioTM TAVR系统多中心注册临床试验完成患者入组。后续阶段的随访评估正在进行中。公司预期在中国获得监管批准后将此产品商品化,以迎合广大AR患者尚未满足的需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159891","BK1100","09996","BK1583"],"gpt_icon":0},{"id":"2484659905","title":"积极捡拾筹码 百亿级私募11月初仓位创今年以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2484659905","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484659905?lang=zh_cn&edition=full","pubTime":"2024-11-18 04:54","pubTimestamp":1731876894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1583","159582","159883","09997","BK1574","09996","BK1222","399300","BK1100","159982"],"gpt_icon":0},{"id":"2483751623","title":"百亿级股票私募仓位指数创今年以来单周加仓幅度最高纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2483751623","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483751623?lang=zh_cn&edition=full","pubTime":"2024-11-16 21:39","pubTimestamp":1731764373,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159883","09996","399300","BK1222","159582","09997","BK1574","BK1100","BK1583","159982"],"gpt_icon":0},{"id":"2483624655","title":"我国在研新药数量跃居全球第二 后续将推动医药工业转型升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2483624655","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483624655?lang=zh_cn&edition=full","pubTime":"2024-11-16 15:04","pubTimestamp":1731740676,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["600056","BK1515","159883","09997","BK1222","06978","09996","BK1161","BK0250","BK0185","BK0082","BK1583","BK0188","BK1191","BK0175","01477","BK0028","BK1574","09939","159992","BK0010","159938","BK1100"],"gpt_icon":0},{"id":"2483563510","title":"陕西平利县一乡村卫生室使用过期导尿包,市监局:罚款2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483563510","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483563510?lang=zh_cn&edition=full","pubTime":"2024-11-16 12:20","pubTimestamp":1731730800,"startTime":"0","endTime":"0","summary":"平利县市监局依法责令其改正上述违法行为,并处罚款5000元。平利县市监局依法作出警告、没收上述超过有效期的药品、罚款10000元的行政处罚。平利县市监局依法作出责令其改正违法行为、没收上述超使用期限的化妆品、处罚款2000元的行政处罚。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-16/doc-incwfpnr9253966.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-16/doc-incwfpnr9253966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09996","BK1222","09997","BK1100","BK1583"],"gpt_icon":0},{"id":"2483310795","title":"【ETF动向】11月15日平安医药及医疗器械创新ETF基金跌2.2%,份额增加2.78亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483310795","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483310795?lang=zh_cn&edition=full","pubTime":"2024-11-16 06:31","pubTimestamp":1731709867,"startTime":"0","endTime":"0","summary":"证券之星消息,11月15日,平安医药及医疗器械创新ETF基金(516820)跌2.2%,成交额1.64亿元。当日份额增加了2.78亿份,最新份额为45.49亿份,近20个交易日份额增加5.99亿份。当日资金净流入6475.12万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为16.12亿元。平安医药及医疗器械创新ETF基金跟踪标的为中证医药及医疗器械创新指数,成立(2021-06-09)以来超额回报为1.34%,近一个月超额回报为-0.06%,管理人为平安基金公司,基金经理为翁欣。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600012773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","159883","BK1515","09997","BK1574","09996","159987","09939","BK1222","BK1161","159938","BK1100"],"gpt_icon":0},{"id":"2483430722","title":"山外山新注册《基于UDI的医疗器械耗材防伪标识系统V2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2483430722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483430722?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:11","pubTimestamp":1731690695,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山外山(688410)新注册了《基于UDI的医疗器械耗材防伪标识系统V2.0》项目的软件著作权。今年以来山外山新注册软件著作权6个,较去年同期减少了45.45%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了2662.69万元,同比增82.54%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111600001669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1583","09996","688410","BK1100","BK0251","159883","BK1574","BK1222"],"gpt_icon":0},{"id":"2483165603","title":"刘泽凡:医疗器械出海如何提升竞争力?","url":"https://stock-news.laohu8.com/highlight/detail?id=2483165603","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483165603?lang=zh_cn&edition=full","pubTime":"2024-11-15 14:31","pubTimestamp":1731652272,"startTime":"0","endTime":"0","summary":"中新经纬11月15日电 题:医疗器械出海如何提升竞争力? 作者 刘泽凡 广开首席产业研究院研究员 近期,上海、北京分别出台《上海市提升生物医药企业国际竞争力行动方案(2024—2027年)》《关于服务支持民营企业拓展海外市场行动方案》,全力支持包括生物医药在内的企业出海。此前,商务部和国务院办公厅也分别出台相关...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OBOIqiasKDf_xMJZM3oS_j0BVaIgCcdHt-P7oBRFnT7dIAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OBOIqiasKDf_xMJZM3oS_j0BVaIgCcdHt-P7oBRFnT7dIAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241115A059AD00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241115A059AD00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1100","BK1574","BK1583","09997","BK1222","09996"],"gpt_icon":0},{"id":"2483397613","title":"沛嘉医疗-B盘中异动 下午盘快速上涨5.45%报4.060港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483397613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483397613?lang=zh_cn&edition=full","pubTime":"2024-11-15 13:07","pubTimestamp":1731647240,"startTime":"0","endTime":"0","summary":"2024年11月15日下午盘13时07分,沛嘉医疗-B股票出现波动,股价大幅拉升5.45%。截至发稿,该股报4.060港元/股,成交量12.2万股,换手率0.02%,振幅5.19%。沛嘉医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.00%。其相关个股中,高视医疗、沛嘉医疗-B、佳兆业健康涨幅较大,振幅较大的相关个股有GUANZE MEDICAL、业聚医疗、高视医疗,振幅分别为10.71%、8.35%、6.67%。神经介入业务部门从事研发神经介入手术医疗器械业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115130721971a6ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115130721971a6ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","09996","BK1574","BK1100"],"gpt_icon":0},{"id":"2483391191","title":"苏州工业园区:加速发展高端产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2483391191","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483391191?lang=zh_cn&edition=full","pubTime":"2024-11-15 12:19","pubTimestamp":1731644378,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["161726","09997","399260","BK1583","BK1222","BK1574","09996","BK1100","159703","159883","399441"],"gpt_icon":0},{"id":"2483954023","title":"港股异动 | 高视医疗(02407)涨超3% 人工晶状体植入系统获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2483954023","media":"智通财经","labels":["Product Release","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483954023?lang=zh_cn&edition=full","pubTime":"2024-11-15 11:25","pubTimestamp":1731641141,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,高视医疗(02407)涨超3%,截至发稿,涨3.33%,报11.16港元,成交额1128.09港元。消息面上,高视医疗发布公告,集团全资附属公司高视泰靓医疗科技有限公司的“人工晶状体植入系统”已获得由广东省药品监督管理局批准的二类医疗器械注册证。公告称,高视泰靓本次获批的人工晶状体植入系统(注册证编号:粤械注准20242161490)由高视泰靓自主设计完成,既可以用于白内障手术中的人工晶状体植入手术,也可用于矫正近视的有晶体眼人工晶状体植入手术。该产品一方面可满足集团旗下的单焦点和多焦点人工晶状体的使用需求,另一方面也可供其它晶体厂家挑选适配使用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02407","BK1100","09996","BK1222","159883","BK1583","09997","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":0.0232},{"period":"1month","weight":-0.0198},{"period":"3month","weight":0.5817},{"period":"6month","weight":0.0847},{"period":"1year","weight":-0.4943},{"period":"ytd","weight":-0.4628}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Peijia Medical Ltd是一家主要从事介入手术医疗器械研发业务的中国控股公司。通过其子公司,该公司主要运营两个业务部门。经导管瓣膜治疗业务部门主要从事研发经导管瓣膜治疗医疗器械业务。神经介入业务部门从事研发神经介入手术医疗器械业务。该公司的主要在研产品包括TaurusOne、TaurusElite和TaurusNXT等。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.087602},{"month":2,"riseRate":0.5,"avgChangeRate":0.022444},{"month":3,"riseRate":0.25,"avgChangeRate":-0.199645},{"month":4,"riseRate":0.666667,"avgChangeRate":0.038325},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.097949},{"month":6,"riseRate":0.6,"avgChangeRate":0.060135},{"month":7,"riseRate":0.4,"avgChangeRate":-0.009656},{"month":8,"riseRate":0.4,"avgChangeRate":-0.07565},{"month":9,"riseRate":0.4,"avgChangeRate":0.044113},{"month":10,"riseRate":0.6,"avgChangeRate":0.006613},{"month":11,"riseRate":0.6,"avgChangeRate":-0.000253},{"month":12,"riseRate":0.5,"avgChangeRate":0.08022}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}